Listen to this page using ReadSpeaker
Posts tagged retina foundation of the southwest

Optogenetic Therapy Takes First Step Forward in Clinical Trial

Retrosense logoRetroSense Therapeutics has reported that three participants have received injections of its potential optogenetic therapy, known as RST-01, in a Phase I/II clinical trial. The patients were given the lowest dose of RST-01, and no adverse ocular events were observed. Furthermore, the treatment showed some biological activity, though RetroSense did not provide details about what that activity was or what it meant.

More information on safety and efficacy will likely be reported about the RetroSense trial after more trial participants have been observed over a longer period of time, and after discussions with the U.S. Food and Drug Administration. Continue Reading…

The Maestro

Dr. David BirchIf you’ve been reading my blog, you’ve heard a lot about clinical trials. They’re the last series of steps in the testing process that potential treatments – whether drug, gene therapy or stem-cell – must go through before they can be approved by the U.S. Food and Drug Administration, or FDA. Clinical trials are experiments, and you can’t conduct a sound experiment without the right subjects – in this case, human beings. Continue Reading…